SYNCOMF
Invest Now
Syncom Formulation (India) Share Price
₹19.78 -0.35 (-1.74%)
21 Nov, 2024 14:24
Start SIP in SYNCOMF
Start SIPPerformance
- Low
- ₹20
- High
- ₹20
- 52 Week Low
- ₹10
- 52 Week High
- ₹28
- Open Price₹20
- Previous Close₹20
- Volume2,405,020
Investment Returns
- Over 1 Month -3.55%
- Over 3 Month + 21.93%
- Over 6 Month + 46.17%
- Over 1 Year + 101.11%
Smart Investing Starts Here Start SIP with Syncom Formulation (India) for Steady Growth!
Syncom Formulation (India) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 56.1
- PEG Ratio
- 1.4
- Market Cap Cr
- 1,859
- P/B Ratio
- 6.5
- Average True Range
- 1.12
- EPS
- 0.35
- Dividend Yield
- 0
- MACD Signal
- -0.11
- RSI
- 47.45
- MFI
- 57.03
Syncom Formulation (India) Financials
Syncom Formulation (India) Technicals
EMA & SMA
Current Price
₹19.78
-0.35
(-1.74%)
- Bullish Moving Average 0
- Bearish Moving Average 0
- 20 Day
- ₹20.47
- 50 Day
- ₹20.33
- 100 Day
- ₹19.05
- 200 Day
- ₹16.83
Resistance and Support
20.36
- R3 21.65
- R2 21.30
- R1 20.71
- S1 19.77
- S2 19.42
- S3 18.83
Syncom Formulation (India) Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-11 | Quarterly Results | |
2024-08-12 | Quarterly Results | |
2024-05-17 | Audited Results | |
2024-02-14 | Quarterly Results | |
2023-11-08 | Quarterly Results |
Syncom Formulation (India) F&O
About Syncom Formulation (India)
- NSE Symbol
- SYNCOMF
- BSE Symbol
- 524470
- Managing Director
- Mr. Vijay Shankarlal Bankda
- ISIN
- INE312C01025
Similar Stocks to Syncom Formulation (India)
Syncom Formulation (India) FAQs
Syncom Formulation (India) share price is ₹19 As on 21 November, 2024 | 14:10
The Market Cap of Syncom Formulation (India) is ₹1859.3 Cr As on 21 November, 2024 | 14:10
The P/E ratio of Syncom Formulation (India) is 56.1 As on 21 November, 2024 | 14:10
The PB ratio of Syncom Formulation (India) is 6.5 As on 21 November, 2024 | 14:10
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.